Versant Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Buy
+2,650
New +$10.2K ﹤0.01% 2096
2026
Q1
Sell
-1,728
Closed -$6.91K 2808
2025
Q4
$6.91K Buy
1,728
+241
+16% +$1.34K ﹤0.01% 2132
2025
Q3
$12.6K Buy
1,487
+1,427
+2,378% +$13.8K ﹤0.01% 1834
2025
Q2
$676 Sell
60
-741
-93% -$6.81K ﹤0.01% 2528
2025
Q1
$7.58K Sell
801
-36
-4% -$364 ﹤0.01% 1861
2024
Q4
$9.42K Buy
837
+787
+1,574% +$13.8K ﹤0.01% 1432
2024
Q3
$1.41K Hold
50
﹤0.01% 1661
2024
Q2
$956 Hold
50
﹤0.01% 1682
2024
Q1
$1.64K Hold
50
﹤0.01% 1416
2023
Q4
$1.65K Hold
50
﹤0.01% 1361
2023
Q3
$1.36K Hold
50
﹤0.01% 1438
2023
Q2
$1.51K Hold
50
﹤0.01% 1470
2023
Q1
$1.62K Hold
50
﹤0.01% 1324
2022
Q4
$1.4K Hold
50
﹤0.01% 1229
2022
Q3
$2K Hold
50
﹤0.01% 1067
2022
Q2
$2K Hold
50
﹤0.01% 1085
2022
Q1
$2K Hold
50
﹤0.01% 1124
2021
Q4
$1K Hold
50
﹤0.01% 1255
2021
Q3
$2K Hold
50
﹤0.01% 1116
2021
Q2
$1K Hold
50
﹤0.01% 1268
2021
Q1
$1K Hold
50
﹤0.01% 1350
2020
Q4
$0 Hold
50
﹤0.01% 1397
2020
Q3
$0 Hold
50
﹤0.01% 1359
2020
Q2
$0 Buy
+50
New +$335 ﹤0.01% 1368
2020
Q1
Sell
-40
Closed 1408
2019
Q4
$0 Hold
40
﹤0.01% 1416
2019
Q3
$0 Buy
+40
New +$287 ﹤0.01% 1424
2019
Q2
Sell
-15
Closed 1486
2019
Q1
$0 Buy
+15
New +$237 ﹤0.01% 1603

Other funds holding EVH

Versant Capital Management's EVH Position: Q2 2026 in Review

Versant Capital Management opened a new position in Evolent Health (EVH) in Q2 2026: 2,650 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #2096 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in EVH as recently as Q4 2025.

Versant Capital Management first reported a position in EVH in Q1 2019 and has held it in 27 quarters since. 12 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Versant Capital Management held 2,650 shares of Evolent Health worth $14.4K as of Q2 2026.
  • Evolent Health was a new Versant Capital Management position in Q2 2026.
  • Evolent Health made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2096 holding.
  • Versant Capital Management first reported a position in Evolent Health in Q1 2019 and has held it in 27 quarters since.
  • 12 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.